TY - JOUR
TI - Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma
AU - San Miguel, Jesús F
AU - Schlag, Rudolf
AU - Khuageva, Nuriet K
AU - Dimopoulos, Meletios A
AU - Shpilberg, Ofer
AU - Kropff, Martin
AU - Spicka, Ivan
AU - Petrucci, Maria Teresa
AU - Palumbo, Antonio
AU - Samoilova, Olga S
AU - others
JO - Chinese Journal of Clinical Oncology
PY - 2013
VL - 31
TODO - 4
SP - 448--455
PB - American Society of Clinical Oncology
SN - 1672-7118, 1993-5145
TODO - null
TODO - null
TODO - null
ER -